NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 13748591 持证商 URSAPHARM Arzneimittel GmbH 包装规格 10 ml 产品名 Pollival 0,5mg/ml 剂型 Augentropfen Monopräparat ja 活性物质 Azelastin hydrochlorid 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/product/pollival-0-5-mg-ml-augentropfen-loesung.645941.html
产品名称:OLOPATADINE HYDROCHLORIDE上市时间:04/27/2023NDA/ANDA/BLA:210901持证商:AMNEALNDC:65162-890-23说明书:批准信:https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=806e8d0f-ff42-4d6e-b840-49e3bf867cb5&type=pdf
产品名称:DRONEDARONE上市时间:04/27/2023NDA/ANDA/BLA:210678持证商:AUROBINDO PHARMA LTDNDC:说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/210678Orig1s000TA_ltr.pdf
产品名称:DROSPIRENONE AND ETHINYL ESTRADIOL上市时间:04/27/2023NDA/ANDA/BLA:90081持证商:DR REDDYS LABS SANDC:说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090081s000ltr.pdf
产品名称:DROSPIRENONE AND ETHINYL ESTRADIOL上市时间:04/27/2023NDA/ANDA/BLA:90081持证商:DR REDDYS LABS SANDC:说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090081s000ltr.pdf
产品名称:HADLIMA上市时间:04/26/2023NDA/ANDA/BLA:761059持证商:SAMSUNG BIOEPIS CO LTDNDC:0006-5032-02,0006-5031-02说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761059Orig1s000ltr.pdf
产品名称:TRIKAFTA (COPACKAGED)上市时间:04/26/2023NDA/ANDA/BLA:217660持证商:VERTEX PHARMS INCNDC:51167-445-01,51167-446-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217660s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217660orig1s000ltr.pdf
产品名称:DEXAMETHASONE上市时间:04/26/2023NDA/ANDA/BLA:217538持证商:BIONPHARMA INCNDC:说明书:批准信:
产品名称:THEOPHYLLINE上市时间:04/26/2023NDA/ANDA/BLA:216300持证商:BIONPHARMA INCNDC:说明书:批准信:
产品名称:LIVTENCITY上市时间:04/26/2023NDA/ANDA/BLA:215596持证商:TAKEDA PHARMS USANDC:64764-800-28,64764-800-56说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215596lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215596Orig1s000ltr.pdf